Structural Features Resulting in Convulsive Activity of Carbapenem Compounds: Effect of C-2 Side Chain

The Journal of Antibiotics

Volumn 48, Issue 5, 1995, Pages 408-416

  Sunagawa, Makoto ^a   Matsumura, Haruki ^a   Sumita, Yoshihiro ^a   Nouda, Hiroshi ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BETAMIPRON; CARBAPENEM DERIVATIVE; CARBOXYL GROUP; CILASTATIN; IMIPENEM; MEROPENEM; PANIPENEM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MOUSE; NEUROTOXICITY; NONHUMAN; PH; PRIORITY JOURNAL; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

ANIMAL; COMPARATIVE STUDY; CONVULSIONS; IMIPENEM; MICE; MICE, INBRED ICR; RECEPTORS, GABA; STRUCTURE-ACTIVITY RELATIONSHIP; THIENAMYCINS;

EID: 0029046103     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.7164/antibiotics.48.408     Document Type: Article

References (21)

1. Cartis, D. R.; C. J. A. Game, G. A. R. Johnston, R. M. McCulloch & R. M. Maclachian: Convulsive action of penicillin. Brain Res. 43: 242 — 245, 1972
2. Michael, C. G.; J. Massey & D. C. Spadaro: Comparative convulsant activity of various penicillins after intracerebral injection in mice. J. Pharm. Pharmac. 25:104-108, 1973
3. Bechtel, T. P.; R. L. Slaughter & T. D. Moore: Seizures associated with high cerebrospinal fluid concentrations of cefazolin. J. Hosp. Pharm. 37: 271—273, 1980
4. Calandra, G.; E. Lydick, J. Carrigan H. Guess: Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: Experience with imipenem/cilastatin. Am. J. Med. 84: 911—918, 1988
5. Calamdra, G. B.; K. R. Brown, L. C. Grad, V. I. Ahonkhai, C. Wang & M. A. Aziz: Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin. Am. J. Med. 78 (Suppl. 6A): 73–78, 1985
6. Sunagawa, M.; H. Matsumura, Y. Ohno, M. Nakamura & M. Fukasawa: Meropenem, a 1-β-methyl carbapenem with low neurotoxic side-effects: Structure-activity relationship for convulsive liability. Program and Abstracts of the 31st Intersci. Conf. on Antimicrob. Agents Chemother., No. 167, p. 126, Chicago, Sept. 29 —Oct. 2, 1991
7. Ohno, Y.; A. Hirose, R. Tsuji, T. Kato, M. Nakamura, J. R. Edwards & J. B. Patel: Behavioral and electroencephalographic studies on the central action of a novel carbapenem: Meropenem. Chemotherapy (Tokyo) 40 (Suppl. 1): 175-181, 1992
8. Patel, J. B. & R. E. Giles: Meropenem, evidence of lack of proconvulsive tendency in mice. J. Antimicrob. Chemother. 24 (Suppl. A): 307–309, 1989
9. Sunagawa, M.; H. Matsumura M. Fukasawa: Structure-activity relationships of carbapenem and penem compounds for the convulsive property. J. Antibiotics 45: 1983–1985, 1992
10. Hori, S.; S. Kurioka, M. Matsuda & J. Shimada: Inhibitory effect of cephalosporins on gamma-aminobutyric acid receptor binding in rat synaptic membranes. Antimicrob. Agents Chemother. 27: 650 — 651, 1985
11. Williams, P. D.; D. B. Bennet & C. R. Comereski: Animal model for evaluating the convulsive liability of β-lactam antibiotics. Antimicrob. Agents Chemother. 32: 758–760, 1988
12. Shimada, J.; S. Hori, K. Kanemitsu, Y. Shoji, S. Nakashio & A. Y. Anagawa: A comparative study on the convulsant activity of carbapenems and β-lactams. Drugs Exp. Clin. Res. 18: 377–381, 1992
13. Takeuchi, Y.; T. Inoue & M. Sunagawa: Studies on the structures of meropenem (SM-7338) and its primary metabolite. J. Antibiotics 46: 827 — 832, 1993
14. Takamura, M.; K. Higashi, H. Fujiwara, M. Sato M. Furukawa: Pummerer reaction of thienamycin-type cyclic vinylogous sulfide and sulfoxide. Chem. Pharm. Bull. 33: 5190–5196, 1985
15. Shibata, T.; K. Iino & Y. Sugimura: Synthesis of optically active 3-mercaptopyrrolidine derivatives. Synthetic intermediates of carbapenem RS-533 and its isomer. Heterocycles 24: 1331–1346, 1986
16. Sunagawa, M.; H. Matsumura, T. Inoue, M. Fukasawa & M. Kato: A novel carbapenem antibiotic SM-7338 structure-activity relationships. J. Antibiotics 43: 519–532, 1990
17. Birnbaum, J.; F. M. Kahan, H. Kropp & J. S. Macdonald: Carbapenems, a new class of beta-lactam antibiotics: Discovery and development of imipenem/ cilastatin. Am. J. Med. 78 (Suppl. 6A): 3 — 21, 1985
18. Naganuma, H.; H. Tokiwa, Y. Hirouchi, Y. Kawahara, J. Fukushige, M. Fukami, K. Hirota, S. Muramatsu, H. Takahagi, K. Inui, Y. Tanigawara, M. Yasuhara, R. Hori & S. Kuwahara: Nephroprotective effect and its mechanism of betamipron (1): Relation of renal transport. Chemotherapy (Tokyo) 39 (Suppl. 3): 166–177, 1991
19. A, benzodiazepine, and glycine receptor binding in relation to lack of central nervous system toxicity in rats. Antimicrob. Agents Chemother. 37: 199 — 202, 1993
20. Suzuki, H.; Y. Sawada, Y. Sugiyama, T. Iga, M. Hanano & R. Spector: Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system. J. Pharmacol. Exp. Ther. 250: 979 — 984, 1989
21. Meulemans, A.; P. Vicart, D. Henzel, J. Mohler & M. Vulpillat: Cefsulodin penetration into rat brain: Extracellular versus total concentration. Chemotherapy (Basel) 32: 393–398, 1986